ArticleIntensive care medicine experimental2023

Identifying a target group for selenium supplementation in high-risk cardiac surgery: a secondary analysis of the SUSTAIN CSX trial.

Quirin Notz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.